The Oxford/AstraZeneca vaccine is less effective against the South Africa variant of COVID-19, researchers have found.
The researchers who developed the jab say it offers only limited protection against mild disease caused by the novel variant E484K.
However, early data also shows that the jab can prospectively protect against more severe disease caused by the mutation.
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí https://www.youtube.com/channel/UCzG5BnqHO8oNlrPDW9CYJog
SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews
Follow us on Twitter: https://twitter.com/skynews and https://twitter.com/skynewsbreak
Like us on Facebook: https://www.facebook.com/skynews
Follow us on Instagram: https://www.instagram.com/skynews
For more content go to http://news.sky.com and download our apps:
Apple https://itunes.apple.com/gb/app/sky-news/id316391924?mt=8
Android https://play.google.com/store/apps/details?id=com.bskyb.skynews.android&hl=en_GB